Synergy Cancer Research Results

Synergy, Synergy: Click to Expand ⟱
Source:
Type:

Synergy — Interaction in which two or more agents, treatments, or biological interventions produce a combined effect greater than would be expected from their individual effects. In pharmacology and cancer research, synergy commonly refers to enhanced therapeutic efficacy when a compound is combined with chemotherapy, radiation, targeted therapy, or another bioactive agent.

Typical modulation in cancer: ↑ synergy is generally favorable when it increases tumor-cell killing, suppresses proliferation, enhances apoptosis or ferroptosis, or improves sensitivity to anticancer therapy. Synergy should be distinguished from simple additive effects and ideally supported by quantitative combination analysis such as combination index, Bliss independence, Loewe additivity, or related methods.

Typical modulation in Alzheimer’s disease: Context-dependent. Synergy may describe enhanced neuroprotective, anti-inflammatory, antioxidant, or cognitive effects produced by combinations of compounds or treatments, but it is not a disease-specific molecular pathway.



Scientific Papers found: Click to Expand⟱
9142- CC,  immuno,    Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC)
- Trial, RCC, NA
GutMicro↑, CD8+↑, CD4+↑, Synergy?, Dose?,
9136- CC,  immuno,    Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic
- Case Report, Melanoma, NA
GutMicro↑, Ingr?, CD8+↑, CR↑, CR↑, Synergy↑,
5973- CDT,    Chemodynamic Therapy via Fenton and Fenton-Like Nanomaterials: Strategies and Recent Advances
- Review, Var, NA
Fenton↑, selectivity↑, Synergy↑,
6645- Cen,    Can Asiatic Acid from Centella asiatica Be a Potential Remedy in Cancer Therapy?—A Review
- Review, Var, NA
TumCD↑, TumCG↓, TumMeta↓, PI3K↓, Akt↓, mTOR↓, P70S6K↓, STAT3↓, N-cadherin↓, β-catenin/ZEB1↓, CLDN1↓, Vim↓, TumAuto↑, *BioAv↓, Casp3↑, ROS↑, MMP15↓, MMP↓, Synergy↑, *toxicity↓,
6020- CGA,  BetaL,    Chlorogenic Acid Enhances Beta‐Lapachone‐Induced Cell Death by Suppressing Autophagy in NQO1‐Positive Cancer Cells
- in-vitro, BC, MDA-MB-231
Synergy↑, Apoptosis↑, PKA↑, eff↑,
6013- CGA,    Advances in Pharmacological Properties, Molecular Mechanisms, and Bioavailability Strategies of Chlorogenic Acid in Cardiovascular Diseases Therapy
- Review, CardioV, NA
*BioAv↝, *BioAv↝, *BP↓, *ROS↓, *NADPH↓, *AntiAg↑, *TXA2↓, *antiOx↑, *cardioP↑, *Inflam↓, *SOD↑, *Catalase↑, *Ferroptosis↓, *NF-kB↓, *JNK↓, *NRF2↑, *HO-1↑, *toxicity↓, *BioAv↓, *BioAv↑, *BioAv↑, Synergy↑,
7183- CHA,    The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells
- in-vitro, AML, HL-60 - in-vitro, AML, KG-1 - in-vitro, lymphoma, U937
TumCD↓, SUV39H↓, CD11b↑, Diff↑, H3K9↓, Synergy↑,
7186- CHA,  TSA,    Improved Therapeutic Effect against Leukemia by a Combination of the Histone Methyltransferase Inhibitor Chaetocin and the Histone Deacetylase Inhibitor Trichostatin A
- in-vitro, AML, NA
SUV39H↓, H3K9↓, Synergy↑,
7171- CHA,    Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201
- vitro+vivo, GBM, DIPG
TumCG↓, TumCP↓, Apoptosis↓, OS↑, H3K9↓, SUV39H↓, Synergy↑, CSCs↓, SOX9↓, HGF/c-Met↓, FGF21↓, EGFR↓, PDGFR-BB↓, Wnt↓, MYCN↑, OLIG2↓, AURKB↓, HO-1↑, P21↑,
6025- Chit,    Glycated chitosan as a new non-toxic immunological stimulant
- vitro+vivo, Var, HeLa
*Imm↑, *BioAv↑, Synergy↑, *toxicity↓, *TNF-α↑, *Obesity↓,
5996- Chit,    NEW CHITOSAN-BASED CHEMO PHARMACEUTICAL DELIVERY SYSTEMS FOR TUMOR CANCER TREATMENT: SHORT-REVIEW
- Review, Var, NA
BioAv↑, Wound Healing↑, DDS↑, toxicity↓, Synergy↑,
6073- CHL,  GEM,    Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis
- in-vitro, PC, NA
ChemoSen↑, Synergy↑, AntiTum↑, TumCP↓, TumCI↓, TumCMig↓, Apoptosis↑, GSH↓, ROS↑, HSP70/HSPA5↑,
6132- CHr,  MET,    Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression
- in-vitro, BC, T47D
Synergy↑, cycD1/CCND1↓, hTERT/TERT↓, TumCP↓, Apoptosis↑, TumCI↓, TumMeta↓, angioG↓, selectivity↑,
6139- CHr,    Chrysin and its nanoformulations in cancer therapy: A systematic review of their radiosensitizing, phototherapy-enhancing potentials
- Review, Var, NA
RadioS↑, PhotoS↑, ROS↑, DNAdam↑, TumCCA↑, TumCD↑, selectivity↑, *ROS↓, *Inflam↓, *DNAdam↓, *antiOx↑, *lipid-P↓, *BioAv↑, Synergy↑, GSH↓, Catalase↓, ALAT↓, Ca+2↓, MDA↑,
6134- CHr,  QC,  RT,    Comparative Pharmacokinetics and Safety of a Micellar Chrysin–Quercetin–Rutin Formulation: A Randomized Crossover Trial
- Trial, Nor, NA
Dose↝, BioAv↑, MPT↑, Synergy↑, Half-Life↑,
6135- CHr,    Chrysin as a Multifunctional Therapeutic Flavonoid: Emerging Insights in Pathogenesis Management: A Narrative Review
- Review, Var, NA - Review, AD, NA
Inflam↓, angioG↓, Apoptosis↑, TumAuto↑, TumCCA↑, BioAv↓, Half-Life↓, BioAv↓, *ROS↓, *hepatoP↑, *RenoP↑, TET1↑, MMP9↓, cMyc↓, Ki-67↓, CBR1↓, ROS↑, ChemoSen↑, Bax:Bcl2↑, PUMA↑, NOTCH1↑, *AntiDiabetic↑, *neuroP↑, *GABA↑, *DNAdam↓, *BDNF↑, *memory↑, *AGEs↓, *Aβ↓, *cardioP↑, *AntiArt↑, Synergy↑, Synergy↑, *Synergy↑, RadioS↑, Synergy↑, ChemoSen↑, eff↑,
6136- CHr,  Tras,    Synergistic anticancer effects of Chrysin and trastuzumab in HER2-Positive breast cancer cells
- in-vitro, BC, SkBr3 - in-vitro, BC, BT474 - in-vitro, Nor, MCF10
Synergy↑, HER2/EBBR2↓, p‑STAT3↓, PD-L1↓, ChemoSen↑,
6124- CHr,  EGCG,    The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells
- in-vitro, HCC, HepG2
TumCG↓, Apoptosis↓, GRP78/BiP↑, eff↑, cl‑Casp7↑, cl‑PARP↑, Synergy↑, UPR↑, ER Stress↑, p‑eIF2α↑, XBP-1↝, Proteasome↓,
2803- CHr,  5-FU,    Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells
- in-vitro, GC, AGS
ChemoSen↑, TumCCA↑, Synergy↑, MDR1↓,
2781- CHr,  PBG,    Chrysin a promising anticancer agent: recent perspectives
- Review, Var, NA
PI3K↓, Akt↓, mTOR↓, MMP9↑, uPA↓, VEGF↓, AR↓, Casp↑, TumMeta↓, TumCCA↑, angioG↓, BioAv↓, *hepatoP↑, *neuroP↑, *SOD↑, *GPx↑, *ROS↓, *Inflam↓, *Catalase↑, *MDA↓, ROS↓, BBB↑, Half-Life↓, BioAv↑, ROS↑, Synergy↑, ROS↑, ROS↑, lipid-P↑, ER Stress↑, NOTCH1↑, NRF2↓, p‑FAK↓, Rho↓, PCNA↓, COX2/PTGS2↓, NF-kB↓, PDK1 / PDPK1↓, PDK3↑, GLUT1↓, Glycolysis↓, mt-ATP↓, Ki-67↓, cMyc↓, ROCK1↓, TOP1↓, TNF-α↓, IL1β↓, CycB/CCNB1↓, CDK2↓, EMT↓, STAT3↓, PD-L1↓, IL2↑,
2782- CHr,    Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives
- Review, Var, NA - Review, Stroke, NA - Review, Park, NA
*antiOx↑, *Inflam↓, *hepatoP↑, *neuroP↑, *BioAv↓, *cardioP↑, *lipidLev↓, *RenoP↑, *TNF-α↓, *IL2↓, *PI3K↓, *Akt↓, *ROS↓, *cognitive↑, Synergy↑, cycD1/CCND1↓, hTERT/TERT↓, VEGF↓, p‑STAT3↓, TumMeta↓, TumCP↓, Synergy↑, Synergy↑, IL1β↓, IL6↓, NF-kB↓, ROS↑, MMP↓, Cyt‑c↑, Apoptosis↑, ER Stress↑, Ca+2↑, TET1↑, Let-7↑, Twist↓, EMT↓, TumCCA↑, Casp3↑, Casp9↑, BAX↑, HK2↓, GlucoseCon↓, lactateProd↓, Glycolysis↓, SHP1↑, N-cadherin↓, E-cadherin↑, UPR↑, PERK↑, ATF4↑, eIF2α↑, RadioS↑, NOTCH1↑, NRF2↓, BioAv↑, Synergy↑,
2784- CHr,    Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review)
- Review, Var, NA
Apoptosis↑, TumCMig↓, *toxicity↝, ChemoSen↑, *BioAv↓, Dose↝, neuroP↑, *P450↓, *ROS↓, *HDL↑, *GSTs↑, *SOD↑, *Catalase↑, *MAPK↓, *NF-kB↓, *PTEN↑, *VEGF↑, ROS↑, MMP↓, Ca+2↑, selectivity↑, PCNA↓, Twist↓, EMT↓, CDKN1C/p57↑, p‑STAT3↑, MMP2↓, MMP9↓, Synergy↑, cycD1/CCND1↓, hTERT/TERT↓, CLDN1↓, TumVol↓, OS↑, COX2/PTGS2↓, Synergy↑, CDK2↓, CDK4↓, selectivity↑, TumCCA↑, E-cadherin↑, HK2↓, HDAC↓,
2785- CHr,    Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
- Review, Var, NA
*NF-kB↓, *COX2/PTGS2↓, *iNOS↓, angioG↓, TOP1↓, HDAC↓, TNF-α↓, IL1β↓, cardioP↑, RenoP↑, neuroP↑, LDL↓, BioAv↑, Synergy↑, cycD1/CCND1↓, hTERT/TERT↓, MMP-10↓, Akt↓, STAT3↓, VEGF↓, EGFR↓, Snail↓, Slug↓, Vim↓, E-cadherin↑, Synergy↑, TET1↑, ROS↑, mTOR↓, PPARα↓, ER Stress↑, Ca+2↑, ERK↓, MMP↑, Cyt‑c↑, Casp3↑, HK2↓, NRF2↓, HO-1↓, MMP2↓, MMP9↓, Fibronectin↓, GRP78/BiP↑, XBP-1↓, p‑eIF2α↑, *AST↓, ALAT↓, ALP↓, LDH↓, COX2/PTGS2↑, Bcl-xL↓, IL6↓, PGE2↓, iNOS↓, DNAdam↑, UPR↑, Hif1a↓, EMT↓, Twist↓, lipid-P↑, CLDN1↓, PDK1 / PDPK1↓, IL10↓, TLR4↓, NOTCH1↑, PARP↑, Mcl-1↓, XIAP↓,
2789- CHr,    Anticancer Activity of Ether Derivatives of Chrysin
- Review, Var, NA
eff↑, COX2/PTGS2↓, PGE2↓, Synergy↑,
2790- CHr,    Chrysin: Pharmacological and therapeutic properties
- Review, Var, NA
*hepatoP↑, *neuroP↓, *ROS↓, *cardioP↑, *Inflam↓, Synergy↑, hTERT/TERT↓, cycD1/CCND1↓, MMP9↓, MMP2↓, TIMP1↑, TIMP2↑, BioAv↑, HK2↓, ROS↑, MMP↓, Casp3↑, ADP:ATP↑, Apoptosis↑, ER Stress↑, UPR↑, GRP78/BiP↝, Synergy↑, Ca+2↑,
6140- Cin,  HCAs,    Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review)
- Review, Var, NA
Dose↝, TumCP↓, TumCCA↑, Apoptosis↑, TumCMig↓, TumCI↓, angioG↓, *Inflam↓, *antiOx↑, *Bacteria↓, *AntiThr↑, *hepatoP↑, *AntiDiabetic↑, *neuroP↑, AntiCan↑, ChemoSen↑, *BioAv↝, *BioAv↑, Synergy↑, CDK1↓, CDK2↓, CDK4↓, cJun↓, cFos↓, Apoptosis↑, PI3K↓, Akt↓, E-cadherin↑, MMP2↓, MMP9↓, TOP1↓, BRCA1↓, ROS↑, BAX↑, Bcl-2↓, XIAP↓, MMP↓, STAT3↓, mTOR↓, NF-kB↓, eff↑, toxicity↓, cardioP↑,
1576- Citrate,    Targeting citrate as a novel therapeutic strategy in cancer treatment
- Review, Var, NA
TCA↓, T-Cell↝, Glycolysis↓, PKM2↓, PFK2?, SDH↓, PDH↓, β-oxidation↓, CPT1A↓, FASN↑, Casp3↑, Casp2↑, Casp8↑, Casp9↑, cl‑PARP↑, Hif1a↓, GLUT1↓, angioG↓, Ca+2↓, ROS↓, eff↓, Dose↓, Synergy↑, Mcl-1↓, HK2↓, IGF-1R↓, PTEN↑, citrate↓, Dose∅, ChemoSen↑, eff↑, eff↑, Synergy↑,
4770- CoQ10,  VitK2,    Cancer cell stiffening via CoQ10 and UBIAD1 regulates ECM signaling and ferroptosis in breast cancer
- in-vitro, BC, MDA-MB-231
other↑, *antiOx↑, Risk↓, other↑, TumMeta↓, ECM/TCF↓, Akt2↓, Ferroptosis↑, Synergy↑,
3994- CoQ10,  Se,    Coenzyme Q10 Supplementation in Aging and Disease
- Review, AD, NA - Review, Park, NA
*AntiAge↑, *cardioP↑, *Inflam↓, *antiOx↑, *lipid-P↓, *QoL↑, *neuroP↑, *Dose↝, *BP↓, *IGF-1↑, *IGFBP1↑, *Synergy↑, *LDL↓, *HDL↑, *Synergy↑, *other↑, *RenoP↑, *ROS↓, *TNF-α↓, *IL6↓, *other↝, *other∅,
1572- Cu,    Recent Advances in Cancer Therapeutic Copper-Based Nanomaterials for Antitumor Therapy
- Review, Var, NA
eff↑, Fenton↑, ROS↑, eff↑, mtDam↑, BAX↑, Bcl-2↓, MMP↓, Cyt‑c↑, Casp3↑, ER Stress↑, CHOP/DDIT3↑, Apoptosis↑, selectivity↑, Synergy↑, Pyro↑, Paraptosis↑, Cupro↑, ChemoSen↑, eff↑,
6200- Cuc,  GEM,    Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
- in-vivo, PC, NA
Synergy↑, TumCG↓, Bcl-xL↓, Bcl-2↓, cMyc↓, Casp↑, STAT3↓, JAK2↓,
3588- CUR,    The effect of curcumin on cognition in Alzheimer’s disease and healthy aging: A systematic review of pre-clinical and clinical studies
- Review, AD, NA
*cognitive↝, *BioAv↑, *Inflam↓, *COX2/PTGS2↓, *iNOS↓, *NF-kB↓, *TNF-α↓, *IL1↓, *IL2↓, *IL6↓, *IL8↓, *IL12↓, *ROS↓, *RNS↓, *antiOx↑, *BBB↑, *BioAv↓, *cognitive↑, *memory↑, *tau↓, *Synergy↑,
3583- CUR,    Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers
- Review, Arthritis, NA
*TNF-α↓, *IL1β↓, *NF-kB↓, *PGE2↓, *COX2/PTGS2↓, *MMPs↓, *Synergy↑,
3582- CUR,  PI,    Therapeutic and Preventive Effects of Piperine and its Combination with Curcumin as a Bioenhancer Against Aluminum-Induced Damage in the Astrocyte Cells
- in-vivo, Nor, NA
*Synergy↑, *IL6↓, *TGF-β↓, *BioAv↑,
3579- CUR,  AgNPs,    Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin
- Review, Nor, NA
*IronCh↑, *BioAv↑, *antiOx↑, *Inflam↓, *BioAv↑, ROS↑, *neuroP↑, *Synergy↑,
3578- CUR,  SIL,    Curcumin, but not its degradation products, in combination with silibinin is primarily responsible for the inhibition of colon cancer cell proliferation
- in-vitro, CRC, DLD1
Synergy↑, BioAv↓, TumCG↓,
3574- CUR,    The effect of curcumin (turmeric) on Alzheimer's disease: An overview
- Review, AD, NA
*antiOx↑, *Inflam↓, *lipid-P↓, *cognitive↑, *memory↑, *Aβ↓, *COX2/PTGS2↓, *ROS↓, *AP-1↓, *NF-kB↓, *TNF-α↓, *IL1β↓, *SOD↑, *GSH↑, *HO-1↑, *IronCh↑, *BioAv↓, *Half-Life↝, *Dose↝, *BBB↑, *BioAv↑, *toxicity∅, *Synergy↑,
4830- CUR,    Curcumin and Its Derivatives Induce Apoptosis in Human Cancer Cells by Mobilizing and Redox Cycling Genomic Copper Ions
- in-vitro, Var, NA
Synergy↑, ROS↑, DNAdam↑, TumCG↓, Apoptosis↑, eff↓, Fenton↑, Synergy↑,
129- CUR,    Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation
- vitro+vivo, Pca, LNCaP
JNK↓, H3K4↓, TumCG↓, Apoptosis↑, Synergy↑,
130- CUR,    Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
BAD↝, BAX↝, Synergy↑,
12- CUR,    Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells
- in-vitro, MB, DAOY
HH↓, Shh↓, Gli1↓, PTCH1↓, cMyc↓, n-MYC↓, cycD1/CCND1↓, Bcl-2↓, NF-kB↓, Akt↓, β-catenin/ZEB1↓, survivin↓, Apoptosis↑, ChemoSen↑, RadioS↑, Synergy↑,
1609- CUR,  EA,    Curcumin and Ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells
- in-vitro, Cerv, NA
Synergy↑, Dose∅, ROS↑, DNAdam↑, P53↑, P21↑, BAX↑, Dose∅,
1978- CUR,    Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells
- in-vitro, Cerv, HeLa
TrxR1↓, ROS↑, DNA-PK↑, Synergy↑, Trx↓, Trx1↓,
6214- CUR,    Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve
- Review, CardioV, NA
TumCD↓, TumCI↓, *Inflam↓, *antiOx↓, *AntiTum↓, NF-kB↓, COX2/PTGS2↓, Casp9↓, ROS↑, BioAv↑, RadioS↑, ChemoSen↑, Imm↑, PhotoS↑, sonoS↑, 5LO↓, iNOS↓, IL2↓, TNF-α↓, Casp9↑, Casp3↑, Bcl-2↓, BAX↑, Apoptosis↑, ER Stress↑, cycD1/CCND1↓, CDK2↓, CycB/CCNB1↓, TumCCA↑, MMPs↓, *radioP↑, chemoP↑, hepatoP↑, cardioP↑, Synergy↑, PhotoS↑, eff↑, ROS↑, GSH↓,
6215- CUR,    Curcumin: biochemistry, pharmacology, advanced drug delivery systems, and its epigenetic role in combating cancer
- Review, Var, NA
*antiOx↑, *Inflam↓, *BioAv↓, NF-kB↓, PI3K↓, Akt↓, Wnt↓, β-catenin/ZEB1↓, DNMTs↓, TumCI↓, TumMeta↓, *CompStab↑, *BioAv↑, angioG↓, VEGF↓, MMPs↓, *ROS↓, *SOD↑, *Catalase↑, *GSTs↑, *HO-1↑, *NRF2↑, mTOR↓, GSK‐3β↓, FOXO1↓, *radioP↑, *IL1↓, *IL6↓, *TNF-α↓, HATs↓, HDAC↓, ROS↑, ROS↑, MMP↓, Casp↑, Cyt‑c↑, COX1↓, COX2/PTGS2↓, PGE2↓, *cytoP450↓, ChemoSen↑, cardioP↑, Synergy↑,
6216- CUR,    Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials
- Review, Var, NA
TumCG↓, angioG↓, EMT↓, TumCI↓, TumMeta↓, *GutMicro↑, *BioAv↓, *HO-1↑, *ROS↓, *COX2/PTGS2↓, *iNOS↓, PKCδ↓, EGFR↓, NF-kB↓, cJun↓, cFos↓, cMyc↓, Akt↓, PI3K↓, CDK4↓, *TNF-α↓, *CRP↓, *IL6↓, MMP9↓, VEGF↓, JAK↓, STAT↓, IL1↓, IL2↓, IL6↓, IL8↓, IL12↓, MCP1/CCL2↓, Apoptosis↑, ER Stress↑, 5LO↓, XO↓, *NRF2↑, *HO-1↑, *AChE↓, *neuroP↑, *glucose↓, *GLUT2↑, *GLUT3↑, *GLUT4↑, *GlucoseCon↑, *AMPK↑, *BMD↑, *MDA↓, *Synergy↑, Synergy↑, P53↑, BAX↑, DNAdam↑, Bcl-2↓, CSCs↓, ALDH↓, CD133↑,
2688- CUR,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, Var, NA - Review, AD, NA
*ROS↓, *SOD↑, p16↑, JAK2↓, STAT3↓, CXCL12↓, IL6↓, MMP2↓, MMP9↓, TGF-β↓, α-SMA↓, LAMs↓, DNAdam↑, *memory↑, *cognitive↑, *Inflam↓, *antiOx↑, *NO↑, *MDA↓, *ROS↓, DNMT1↓, ROS↑, Casp3↑, Apoptosis↑, miR-21↓, LC3II↓, ChemoSen↑, NF-kB↓, CSCs↓, Nanog↓, OCT4↓, SOX2↓, Synergy↑, Sp1/3/4↓, miR-27a-3p↓, ZBTB10↑, SOX9?, ChemoSen↑, VEGF↓, XIAP↓, Bcl-2↓, cycD1/CCND1↓, BioAv↑, Hif1a↓, EMT↓, BioAv↓, PTEN↑, VEGF↓, Akt↑, EZH2↓, NOTCH1↓, TP53↑, NQO1↑, HO-1↑,
9104- CV,  SDT,  PDT,    Engineered microalgae for photo-sonodynamic synergistic therapy in breast cancer treatment
- Study, BC, NA
Dose↝, ROS↑, Synergy↑, TumVol↓,
9107- CV,  VitB1/Thiamine,    Assessment of Antioxidant and Anticancer Activities of Microgreen Alga Chlorella vulgaris and Its Blend with Different Vitamins
- in-vitro, Var, PC3 - in-vitro, Liver, HepG2 - in-vitro, CRC, HCT116
AntiTum↑, Synergy↑, Ingr↝,
9037- CV,  SP,    Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence
- Review, Nor, NA
*NRF2↑, *NF-kB↓, *antiOx↑, *BP↝, *GutMicro↑, *Ingr?, *Synergy↑, *antiOx↑, *ROS↓, *toxicity↝, *MMP↑, *ATP↑, *MitoP↑, *lipid-P↓, *MDA↓, *SOD↑, *GPx↑, *TAC↑, *NK cell↑, *IFN-γ↑, *CRP↓, *SCFAs↑, *TC↓, *LDL↓, *TG/TAG↓, *toxicity↝, AntiTum↑, Ki-67↓, ER-α36↓, P53↑, P21↑, TumCCA↑, Bax:Bcl2↑, Apoptosis↑, Synergy↑,

Showing Research Papers: 101 to 150 of 499
Prev Page 3 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 499

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 4,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 1,   antiOx↑, 8,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 4,   Catalase↑, 3,   Fenton↑, 5,   frataxin↑, 1,   GPx↓, 3,   GPx↑, 3,   GPx4↓, 5,   GPx4↑, 1,   GSH↓, 23,   GSH↑, 1,   GSH↝, 1,   GSR↑, 1,   GSSG↑, 1,   GSTs↓, 1,   H2O2↑, 6,   HO-1↓, 3,   HO-1↑, 11,   hyperG↓, 1,   Iron↑, 5,   i-Iron↑, 2,   Keap1↑, 1,   lipid-P?, 1,   lipid-P↓, 3,   lipid-P↑, 11,   MDA↓, 2,   MDA↑, 5,   NQO1↑, 3,   NRF2↓, 11,   NRF2↑, 15,   PrxI↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 2,   ROS↓, 24,   ROS↑, 197,   ROS⇅, 4,   i-ROS↑, 2,   mt-ROS↑, 3,   SOD↓, 6,   SOD↑, 3,   TAC↓, 1,   Trx↓, 3,   Trx↑, 2,   Trx1↓, 1,   Trx2↓, 1,   TrxR↓, 4,   TrxR↑, 2,   TrxR1?, 1,   TrxR1↓, 1,   xCT/SLC7A11↓, 5,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 2,   IronCh↑, 1,   Mets↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   BCR-ABL↓, 1,   CDC2↓, 3,   CDC25↓, 2,   compI↓, 4,   compIII↓, 4,   compV↓, 1,   EGF↓, 2,   ETC↓, 2,   ETC↑, 1,   ETC↝, 1,   Insulin↓, 2,   MFN2↑, 1,   mitResp↓, 2,   mitResp↑, 3,   Mortalin↓, 1,   mtDam↑, 14,   OCR↓, 3,   OCR↑, 3,   OXPHOS↓, 9,   OXPHOS↑, 7,   OXPHOS↝, 2,   PDH↓, 1,   PDH↑, 5,   p‑PDH↑, 1,   PGC-1α↑, 1,   PINK1↑, 1,   SDH↓, 1,   SIRT3↓, 1,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 5,   ACC↑, 3,   ACLY↓, 4,   p‑ACLY↓, 1,   ACSL4↑, 2,   adiP↑, 1,   Alanine↓, 1,   ALAT↓, 4,   ALAT↑, 1,   AMP↑, 1,   AMPK↑, 18,   ATP↓, 14,   ATP↑, 2,   mt-ATP↓, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   citrate↓, 2,   CPT1A↓, 1,   ECAR↓, 1,   FASN↓, 4,   FASN↑, 1,   GAPDH↓, 1,   glucoNG↓, 1,   glucose↓, 1,   glucose↝, 1,   GlucoseCon↓, 7,   GlucoseCon↑, 1,   GlutMet↓, 1,   glyC↓, 1,   Glycine↓, 1,   Glycolysis↓, 41,   Glycolysis↑, 1,   Glycolysis↝, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 3,   p‑GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   Histones↝, 1,   HK1↓, 1,   HK2↓, 18,   HMG-CoA↓, 9,   KeyT↑, 1,   lactateProd↓, 12,   lactateProd↑, 1,   LDHA↓, 7,   LDL↓, 3,   lipoGen↓, 2,   MCT4↓, 1,   NAD↓, 1,   NADH:NAD↓, 1,   NADPH↓, 4,   NADPH↑, 2,   PDHB↓, 1,   PDK1 / PDPK1↓, 9,   PDK3↑, 1,   PDKs↓, 10,   PFK↓, 2,   PFK1↓, 1,   PFK2?, 1,   PKM2↓, 12,   PKM2↑, 1,   PLA2↓, 1,   Pyruv↓, 1,   SCD1↓, 1,   SIRT1↓, 3,   SIRT1↑, 4,   SIRT2↓, 2,   SREBP2↓, 2,   TCA↓, 3,   TCA↑, 2,   TS↓, 1,   Warburg↓, 13,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 3,   APAF1↑, 2,   Apoptosis?, 2,   Apoptosis↓, 4,   Apoptosis↑, 142,   ASK1↑, 1,   BAD↑, 4,   BAD↝, 1,   Bak↑, 5,   BAX↓, 3,   BAX↑, 68,   BAX↝, 2,   Bax:Bcl2↑, 20,   Bcl-2↓, 75,   Bcl-2↑, 2,   Bcl-2↝, 1,   Bcl-xL↓, 17,   Bcl-xL↑, 1,   BID↑, 1,   BIM↑, 7,   BNIP3↑, 1,   Casp↑, 23,   Casp1↑, 1,   Casp12?, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 3,   Casp3↑, 83,   cl‑Casp3↑, 14,   cl‑Casp3⇅, 1,   proCasp3↑, 2,   pro‑Casp3↑, 1,   Casp7↑, 7,   cl‑Casp7↑, 3,   Casp8↓, 1,   Casp8↑, 8,   cl‑Casp8↑, 2,   proCasp8↑, 2,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 45,   cl‑Casp9↑, 6,   proCasp9↑, 2,   CellShr↑, 2,   cFLIP↓, 2,   Cupro↑, 1,   Cyt‑c↑, 45,   Diablo↑, 4,   DR5↑, 14,   FADD↑, 3,   Fas?, 1,   Fas↑, 10,   FasL↑, 2,   Ferroptosis↓, 1,   Ferroptosis↑, 15,   GSDME-N↑, 1,   HEY1↓, 1,   IAP1↓, 4,   IAP2/BIRC3↓, 1,   cl‑IAP2/BIRC3↑, 1,   ICD↑, 2,   iNOS↓, 7,   iNOS↑, 2,   Mcl-1↓, 17,   Mcl-1↑, 1,   MDM2↓, 3,   MDM2↑, 1,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↑, 3,   Necroptosis↑, 3,   necrosis↑, 2,   NOXA↑, 1,   p38↓, 3,   p38↑, 6,   p‑p38↓, 1,   p‑p38↑, 2,   Paraptosis↑, 2,   PUMA↑, 3,   Pyro↑, 4,   RIP3↑, 1,   p‑RIP3↑, 1,   survivin↓, 27,   TNFR 1↑, 1,   TRAIL↑, 1,   TumCD↓, 2,   TumCD↑, 22,   XIAP↓, 15,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 77,   Akt↑, 11,   p‑Akt↓, 19,   Akt2↓, 1,   AMPKα↑, 1,   BRAF↓, 1,   CK2↓, 4,   cSrc↓, 1,   DYRK1B↓, 1,   EF-1α↓, 1,   EGFR↓, 23,   ERK↓, 15,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 11,   FGFR1↓, 1,   FOXD3↑, 1,   HCAR2↑, 1,   HER2/EBBR2↓, 9,   HGF/c-Met↓, 1,   IGF-1R↓, 4,   IGF-1R↑, 1,   IKKα↓, 3,   IκB↓, 1,   IκB↑, 1,   JAK↓, 3,   JAK1↓, 2,   JAK2↓, 8,   JAK3↓, 1,   JNK↓, 3,   JNK↑, 11,   p‑JNK↓, 3,   p‑JNK↑, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 11,   MAPK↑, 7,   MAPK↝, 1,   p‑MAPK↓, 1,   MEK↓, 6,   mTOR↓, 49,   mTOR↑, 2,   mTOR↝, 1,   p‑mTOR↓, 4,   mTORC2↓, 1,   p70S6↓, 1,   P70S6K↓, 3,   p‑P70S6K↓, 3,   P90RSK↓, 1,   PDGFR-BB↓, 2,   p‑PDGFR-BB↓, 1,   PFKFB2↓, 1,   PI3K?, 1,   PI3K↓, 58,   PI3K↑, 4,   p‑PI3K↓, 3,   PI3K/Akt↓, 1,   PKA↓, 1,   PKA↑, 1,   PKCδ↓, 5,   PP2A↑, 1,   PTEN↑, 12,   Raf↓, 2,   c-Raf↓, 1,   RAS↓, 6,   RCC1↓, 1,   p‑S6K↓, 1,   SHP1↑, 2,   Sp1/3/4↓, 7,   Src↓, 1,   STAT↓, 2,   STAT3↓, 46,   STAT3↝, 1,   p‑STAT3↓, 9,   p‑STAT3↑, 4,   STAT4↓, 2,   STAT5↓, 2,   STAT6↓, 2,   STK11/LKB1↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 1,   ATF4↓, 1,   ATF4↑, 7,   ChrMod↝, 1,   cJun↓, 7,   cJun↑, 3,   cMyc↓, 24,   DNMT1↓, 7,   DNMT3A↓, 2,   DNMT3B↓, 1,   DNMTs↓, 7,   EZH2↓, 3,   FOXM1↓, 3,   FOXO↑, 1,   FOXO1↓, 3,   FOXO3↓, 2,   FOXO3↑, 8,   FOXO4↓, 1,   FOXO4↑, 1,   H3↑, 2,   ac‑H3↑, 3,   H3K4↓, 1,   H3K9↓, 3,   H4↑, 1,   ac‑H4↑, 3,   HATs↓, 3,   HATs↑, 1,   HDAC↓, 21,   HDAC1↓, 3,   HDAC2↓, 4,   HDAC3↓, 3,   HDAC6↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   KLF2↓, 1,   KLF4↓, 1,   KLF5↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-126↑, 1,   miR-139-5p↑, 1,   miR-155↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-21↓, 2,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 1,   miR-29b↓, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 2,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   Myc↓, 4,   Myc↑, 1,   MYCN↑, 1,   n-MYC↓, 2,   NDRG1↑, 1,   OCT4↓, 9,   OLIG2↓, 1,   other↓, 5,   other↑, 9,   other⇅, 1,   other↝, 12,   PCAF↓, 1,   PhotoS↑, 3,   sonoS↑, 2,   SOX2↓, 5,   SOX4↓, 2,   SOX9?, 1,   SOX9↓, 1,   SUV39H↓, 3,   TCF-4↓, 1,   tumCV?, 1,   tumCV↓, 40,   tumCV↑, 2,   tumCV∅, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 10,   cl‑CHOP/DDIT3↑, 1,   eIF2α↑, 3,   p‑eIF2α↑, 2,   ER Stress↑, 38,   GRP78/BiP↓, 2,   GRP78/BiP↑, 9,   GRP78/BiP↝, 1,   GRP94↑, 1,   HSP27↓, 4,   HSP70/HSPA5↓, 7,   HSP70/HSPA5↑, 4,   HSP72↑, 1,   HSP90↓, 9,   HSPs↓, 1,   HSPs↑, 1,   IRE1↑, 3,   p‑IRE1↑, 1,   PERK↑, 5,   Proteasome?, 1,   Proteasome↓, 3,   UPR↑, 10,   XBP-1↓, 1,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 2,   ATG7↑, 2,   autoF↓, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 9,   p‑Beclin-1/ATG6↑, 1,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B↑, 2,   LC3II↓, 1,   LC3II↑, 10,   LC3s↓, 1,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 5,   p62↑, 6,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 1,   TumAuto↑, 39,   TumAuto⇅, 2,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   BRCA1↓, 1,   DNA-PK↑, 2,   DNAdam↑, 46,   DNArepair↓, 3,   DNArepair↑, 1,   ERCC1↓, 1,   ERCC3↑, 1,   m-FAM72A↓, 1,   hTERT/TERT↓, 10,   MGMT↓, 1,   NKX3.1↓, 1,   p16↑, 1,   P53↓, 2,   P53↑, 43,   p‑P53↓, 1,   p‑P53↑, 3,   PARP↑, 10,   p‑PARP↑, 1,   cl‑PARP↓, 1,   cl‑PARP↑, 39,   cl‑PARP↝, 1,   PARP1↑, 1,   cl‑PARP1↑, 3,   PCNA↓, 14,   POLD1↓, 1,   SIRT6↓, 1,   Telomerase↓, 7,   TOP1↓, 5,   TOP2↓, 2,   TOP2↑, 1,   TP53↓, 2,   TP53↑, 3,   XRCC1↓, 1,   γH2AX↑, 5,  

Cell Cycle & Senescence(tgid=11) ⓘ

AURKB↓, 1,   CC(CDKs/cyclins)↓, 2,   CDK1↓, 10,   CDK2↓, 23,   CDK4↓, 30,   CDK4↑, 3,   CDK6↓, 9,   CDK6↑, 4,   CDKN1C/p57↑, 1,   CHK1↓, 2,   p‑CHK1↑, 1,   Chk2↓, 1,   ChrCon↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 5,   CycB/CCNB1↓, 13,   cycD1/CCND1↓, 45,   CycD3↓, 3,   cycE/CCNE↓, 16,   cycE1↓, 1,   E2Fs↓, 2,   GADD45A↑, 1,   Ki-67↓, 26,   Ki-67↑, 1,   mitA↑, 2,   P21?, 2,   P21↓, 4,   P21↑, 28,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 10,   pRB↓, 1,   p‑pRB↓, 2,   RB1↑, 1,   p‑RB1↓, 3,   RRM2↓, 1,   Securin↓, 1,   TubPol↓, 1,   TumCCA?, 1,   TumCCA↓, 4,   TumCCA↑, 111,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 5,   ALDH1A1↓, 1,   CD133↓, 4,   CD133↑, 1,   CD24↓, 1,   cFos↓, 7,   cMYB↓, 2,   CSCs?, 1,   CSCs↓, 41,   CSCsMark↓, 1,   Diff↓, 3,   Diff↑, 6,   FGF↓, 1,   Gli↓, 1,   Gli1↓, 6,   HH↓, 8,   HMGCR↓, 1,   HMGCR↑, 1,   HMGCR⇅, 1,   IGF-1?, 1,   IGF-1↓, 7,   IGFBP1↑, 2,   IGFBP3↑, 1,   Ki-67↓, 26,   Ki-67↑, 1,   Let-7↑, 2,   LRP6↓, 1,   mTORC1↓, 5,   p‑mTORC1↓, 1,   Nanog↓, 11,   Nestin↓, 3,   NOTCH↓, 6,   NOTCH↑, 2,   NOTCH1↓, 8,   NOTCH1↑, 4,   NOTCH2↑, 1,   NOTCH3↓, 3,   OGFr↑, 1,   p300↓, 1,   PTCH1↓, 3,   PTCH2↓, 2,   SAL↑, 1,   Shh↓, 4,   Smo↓, 2,   TumCG?, 1,   TumCG↓, 83,   TumCG↑, 3,   TumCP?, 1,   TumCP↓, 82,   TumCP↑, 2,   tyrosinase↓, 1,   Wnt↓, 23,   Wnt↑, 2,   Wnt/(β-catenin)↓, 1,  

Migration(tgid=13) ⓘ

annexin II↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 2,   AP-1↓, 7,   AXL↓, 1,   BACH1↓, 1,   Ca+2↓, 2,   Ca+2↑, 16,   CAFs/TAFs↓, 1,   cal2↑, 1,   Cal9↑, 1,   CD11b↑, 2,   Cofilin↓, 1,   COL1↓, 2,   E-cadherin↓, 4,   E-cadherin↑, 31,   EMT↓, 54,   EMT↑, 2,   FAK↓, 5,   p‑FAK↓, 2,   fascin↓, 2,   Fibronectin↓, 7,   GLI2↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB4↓, 1,   KAI1/CD82↑, 1,   KRAS↓, 2,   L-sel↑, 1,   LAMs↓, 2,   MALAT1↓, 3,   MET↓, 1,   MMP-10↓, 1,   MMP1↓, 4,   MMP13↓, 1,   MMP15↓, 1,   MMP16↓, 1,   MMP2↓, 48,   MMP2↑, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 57,   MMP9↑, 2,   MMPs↓, 20,   MUC1↑, 1,   MUC4↓, 1,   N-cadherin↓, 18,   PAK1↓, 1,   PDGF↓, 2,   RECK↑, 1,   Rho↓, 1,   ROCK1↓, 3,   Slug↓, 10,   Smad1↓, 2,   SMAD2↓, 1,   SMAD3↓, 1,   Snail?, 1,   Snail↓, 15,   STAC2↓, 1,   T-cadherin↓, 1,   TET1↑, 4,   TGF-β↓, 12,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP1↑, 4,   TIMP2↓, 2,   TIMP2↑, 4,   pol-TregCell↓, 1,   TRIB3↑, 1,   TSP-1↑, 4,   TumCA↓, 2,   TumCI↓, 62,   TumCMig↓, 51,   TumCMig↑, 1,   TumMeta?, 1,   TumMeta↓, 44,   TumMeta↑, 3,   Twist↓, 8,   uPA↓, 9,   uPAR↓, 2,   Vim?, 1,   Vim↓, 22,   Zeb1↓, 12,   Zeb1↑, 1,   ZEB2↓, 2,   α-SMA↓, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 30,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 69,   angioG↑, 2,   CD31/PECAM-1↓, 1,   ECM/TCF↓, 1,   eNOS↓, 2,   eNOS↑, 1,   HIF-1↓, 6,   Hif1a↓, 40,   Hif1a↑, 1,   Hypoxia↓, 2,   NO↓, 4,   NO↑, 3,   VCAM-1↓, 3,   VEGF↓, 69,   VEGFR1↓, 3,   VEGFR2/KDR/Flk1↓, 10,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 5,   BBB∅, 1,   CellMemb↑, 1,   CLDN1↓, 3,   CLDN2↓, 1,   CLDN2↑, 1,   CLDN7↑, 1,   EPR↓, 1,   EPR↑, 3,   GLUT1↓, 7,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 62,   MMP↑, 4,   MMP↝, 1,   MPT↑, 4,   SMCT1∅, 1,   TRPM7↓, 1,   TRPV1↓, 1,   TRPV1↑, 1,   TRPV2↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↑, 4,   CD44↓, 7,   CD47↓, 1,   CD59↑, 1,   CD8+↑, 10,   COX1↓, 1,   COX2/PTGS2↓, 55,   COX2/PTGS2↑, 3,   CXCL12↓, 2,   CXCR4↓, 10,   DCells↑, 1,   DR4↑, 5,   Eos↑, 1,   FOXP3↓, 1,   FOXP3↑, 1,   HCAR2↑, 1,   HMGB1↓, 3,   ICAM-1↓, 2,   IFN-γ↓, 3,   IFN-γ↑, 3,   IL1↓, 1,   IL10↓, 4,   IL10↑, 1,   IL12↓, 1,   IL12↑, 2,   IL1α↓, 1,   IL1β↓, 14,   IL1β↑, 1,   IL2↓, 3,   IL2↑, 4,   IL4↓, 2,   IL4↑, 2,   IL6↓, 24,   IL8↓, 6,   Imm↑, 26,   Imm↝, 3,   INF-γ↑, 1,   Inflam↓, 22,   pol-M1↑, 1,   M2 MC↓, 3,   MCP1/CCL2↓, 6,   MIP-1β↑, 1,   MIP2↓, 1,   MyD88↑, 1,   NF-kB↓, 73,   NF-kB↑, 4,   NF-kB↝, 1,   p‑NF-kB↓, 1,   NK cell↑, 10,   NLRP3↓, 2,   p65↓, 4,   ac‑p65↓, 1,   PD-1↓, 4,   PD-L1↓, 7,   PD-L1↑, 1,   PGE1↓, 1,   PGE2↓, 21,   PSA↓, 6,   PSA∅, 1,   T-Cell↑, 3,   T-Cell↝, 1,   TCF↓, 1,   TCF↑, 1,   Th1 response↑, 4,   Th17↑, 1,   Th2↑, 1,   TIM-3↑, 1,   TLR4↓, 2,   TLR4↑, 1,   TNF-α↓, 18,   TNF-α↑, 4,   TRADD↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

pH↓, 2,   pH↑, 1,   pH↝, 1,   e-pH↑, 4,   i-pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 2,   PTN↓, 1,   SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ADRB2↓, 1,   AR↓, 12,   COMT↓, 2,   CYP19↓, 1,   ER-α36↓, 4,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   Estro↝, 1,   EstroRS/ERS↑, 1,   FGF21↓, 1,   GR↑, 1,   PPARα↓, 2,   PPARα↑, 1,   PPARγ↓, 1,   PPARγ↑, 4,   RANKL↓, 1,   SXR↓, 1,   SXR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   BioAv↓, 23,   BioAv↑, 37,   BioAv↝, 13,   BioEnh↑, 1,   CBR1↓, 1,   chemoR↓, 2,   ChemoSen?, 3,   ChemoSen↓, 3,   ChemoSen↑, 161,   ChemoSen⇅, 2,   CompStab↝, 1,   CYP1A1↓, 1,   CYP1A1↑, 2,   CYP1A2↓, 2,   CYP1B1↓, 1,   CYP2C9↓, 1,   CYP3A4↓, 3,   DDS↑, 1,   Dose?, 6,   Dose↓, 5,   Dose↑, 10,   Dose↝, 64,   Dose∅, 15,   eff↓, 34,   eff↑, 96,   eff↝, 7,   eff∅, 2,   GSTP1/GSTπ↓, 2,   GSTZ1↓, 1,   Half-Life↓, 8,   Half-Life↑, 4,   Half-Life↝, 7,   Half-Life∅, 1,   MDR1↓, 9,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 11,   P-gp/ABCB1↝, 1,   P-gp/ABCB1∅, 1,   P450↓, 2,   RadioS?, 1,   RadioS↑, 53,   selectivity?, 1,   selectivity↓, 1,   selectivity↑, 80,   selectivity↝, 1,   Synergy?, 2,   Synergy↓, 1,   Synergy↑, 524,   Synergy↝, 1,   Synergy∅, 1,   TET2↑, 2,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   ALAT↓, 4,   ALAT↑, 1,   ALB∅, 1,   ALP↓, 2,   AR↓, 12,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 3,   BloodF⇅, 1,   BRAF↓, 1,   BRCA1↓, 1,   CRP↓, 2,   CRP∅, 1,   E6↓, 2,   E7↓, 2,   EGFR↓, 23,   ERα/ESR1↓, 1,   EstroRS/ERS↑, 1,   EZH2↓, 3,   Ferritin↓, 2,   FOXM1↓, 3,   HER2/EBBR2↓, 9,   hTERT/TERT↓, 10,   IL6↓, 24,   IRes↓, 1,   KeyT↑, 1,   KRAS↓, 2,   LDH↓, 11,   p‑LDH↓, 1,   Myc↓, 4,   Myc↑, 1,   NOS2↓, 1,   PD-L1↓, 7,   PD-L1↑, 1,   Polyps↓, 1,   PSA↓, 6,   PSA∅, 1,   RBC↑, 1,   TG/TAG↓, 1,   TP53↓, 2,   TP53↑, 3,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 2,   AntiCan↑, 37,   AntiCan∅, 1,   antiNeop↑, 3,   AntiTum↓, 3,   AntiTum↑, 19,   cachexia↓, 1,   cardioP↑, 5,   CardioT↓, 1,   chemoP?, 1,   chemoP↑, 25,   chemoPv↑, 11,   ChemoSideEff↓, 13,   CR↑, 2,   fatigue↓, 3,   hepatoP↓, 1,   hepatoP↑, 6,   memory↑, 1,   Mucositis↓, 1,   neuroP↑, 5,   NP/CIPN↓, 3,   ORR↑, 1,   OS↑, 34,   OS∅, 1,   Pain↓, 1,   PDE4↓, 1,   PFS↓, 1,   PFS↑, 3,   PFS∅, 1,   Pin1↓, 2,   QoL↑, 9,   QoL∅, 2,   radioP↑, 9,   Remission↑, 3,   RenoP↑, 4,   Risk↓, 25,   Risk↑, 2,   Risk∅, 1,   Sleep↑, 1,   toxicity↓, 25,   toxicity↑, 3,   toxicity↝, 11,   toxicity∅, 5,   TumVol↓, 23,   TumW↓, 11,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 3,   GutMicro↑, 9,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↑, 1,   Ingr↝, 7,   Poly↑, 1,  
Total Targets: 977

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 5,   antiOx↑, 78,   ARE↑, 1,   Catalase↑, 31,   Copper↓, 1,   Fenton↓, 1,   GPx↑, 23,   GPx4↑, 2,   GSH↑, 25,   GSR↑, 3,   GSSG↓, 1,   GSSG∅, 1,   GSTs↑, 9,   H2O2↓, 2,   H2O2↑, 1,   H2O2∅, 1,   HDL↑, 3,   HDL∅, 1,   HO-1?, 2,   HO-1↓, 1,   HO-1↑, 22,   Iron↓, 1,   i-Iron↓, 1,   Keap1↓, 3,   Keap1↝, 1,   lipid-P↓, 29,   MDA↓, 22,   MDA↑, 1,   MPO↓, 5,   NQO1↑, 1,   Nrf1↑, 2,   NRF2↑, 44,   Prx↑, 1,   RNS↓, 2,   ROS?, 2,   ROS↓, 84,   ROS↝, 1,   mt-ROS?, 1,   SAM-e↑, 1,   selenoP↑, 1,   SOD↑, 44,   SOD2↑, 2,   TAC↑, 8,   TBARS↓, 2,   Trx↑, 1,   Trx1↑, 1,   uricA↓, 1,   VitC↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 5,   selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↑, 1,   compII↑, 1,   compIII↑, 1,   compIV↑, 2,   DRP1/DNM1L↓, 1,   EGF↓, 1,   ETC↑, 1,   FIS1↓, 2,   Insulin↑, 1,   mtDam↓, 3,   OCR↑, 1,   PGC-1α↑, 2,   PGC-1α↝, 1,   TFAM↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 3,   ACC↓, 1,   adiP↑, 1,   ALAT↓, 10,   AMPK↓, 1,   AMPK↑, 9,   ATP↓, 1,   ATP↑, 9,   ATP↝, 1,   cytoP450↓, 1,   FABP4↓, 1,   FASN↓, 1,   glucose↓, 6,   glucose↝, 1,   GlucoseCon↑, 2,   GSK‐3β↓, 9,   p‑GSK‐3β↑, 1,   H2S↑, 1,   LDL↓, 10,   lipidLev↓, 3,   NAD↓, 1,   NAD↑, 1,   NAD↝, 1,   NADPH↓, 1,   NADPH↑, 1,   PONs↑, 1,   SCFAs↑, 1,   SIRT1↑, 8,   SREBF2⇅, 1,   SREBP1/SREBF1↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 2,   Apoptosis↓, 7,   BAX↓, 4,   BAX↑, 1,   Bax:Bcl2↓, 2,   Bcl-2↓, 2,   Bcl-2↑, 3,   Casp↓, 1,   Casp12↓, 1,   Casp3?, 1,   Casp3↓, 8,   Casp3↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 2,   Casp9↑, 1,   Cyt‑c↓, 3,   Fas↓, 1,   FasL↓, 1,   Ferroptosis↓, 4,   GranB/GZMB↓, 1,   iNOS↓, 12,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 5,   Akt↑, 5,   AKT1↓, 1,   Akt2↓, 1,   AMPKα↑, 1,   CREB↑, 2,   p‑CREB↑, 2,   EGFR↓, 1,   ERK↓, 3,   ERK↑, 2,   IKKα↓, 1,   JNK↓, 2,   p‑JNK↓, 1,   MAPK↓, 7,   MAPK↑, 2,   mTOR↓, 3,   mTOR↑, 2,   PI3K↓, 5,   PI3K↑, 2,   PKCδ?, 1,   PKCδ↓, 3,   PKCδ↑, 2,   PTEN↓, 1,   PTEN↑, 1,   RAS↓, 1,   STAT↓, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 2,   p‑cMyc↑, 1,   HDAC↓, 1,   HDAC↑, 1,   other↓, 3,   other↑, 14,   other↝, 14,   other?, 1,   other∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 5,   GRP78/BiP↓, 2,   GRP78/BiP↑, 1,   UPR↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↓, 1,   LC3II↑, 1,   MitoP↑, 3,   p62↓, 1,   p62↑, 2,   PARK2↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 5,   P53↓, 1,   PARP1↓, 1,   Telomerase↓, 1,   TOP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   GADD45A↑, 1,   Ki-67↓, 1,   Ki-67↑, 1,   P21↓, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMPs↑, 1,   CEBPA↓, 1,   Choline↑, 1,   Diff↝, 1,   GH↑, 1,   IGF-1↑, 1,   IGFBP1↑, 1,   Ki-67↓, 1,   Ki-67↑, 1,   neuroG↑, 1,   TumCG∅, 1,   Wnt↑, 2,  

Migration(tgid=13) ⓘ

AntiAg↓, 2,   AntiAg↑, 8,   AP-1↓, 3,   Ca+2?, 1,   Ca+2↓, 2,   Ca+2↑, 1,   Ca+2↝, 3,   Cartilage↑, 3,   LRP1↑, 1,   MLC2/MYL9↝, 1,   MMP2↓, 1,   MMP9↓, 1,   MMPs↓, 3,   MUC1↑, 1,   serineP↓, 1,   TGF-β↓, 3,   TGF-β↑, 1,   TGF-β1↓, 1,   uPA↑, 1,   α-SMA↝, 1,   β-catenin/ZEB1↑, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 3,   angioG↑, 2,   eNOS↓, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 1,   NO?, 1,   NO↓, 9,   NO↑, 1,   TXA2↓, 1,   VCAM-1↓, 6,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 2,   BBB↑, 15,   BBB↝, 1,   EPR↑, 1,   GastroP↑, 2,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   IBI↑, 3,   memfluid↑, 1,   MMP↑, 8,   MUC19↓, 1,   MUC2↓, 1,   OCLN↑, 1,   OCLN↝, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPV3↑, 1,   VGSC↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD4+↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 19,   COX2/PTGS2↑, 1,   ICAM-1↓, 3,   IFN-γ↓, 3,   IFN-γ↑, 2,   IL1?, 1,   IL1↓, 3,   IL10↓, 3,   IL10↑, 4,   IL12↓, 1,   IL17↓, 3,   IL18↓, 2,   IL1β↓, 22,   IL2↓, 2,   IL33↓, 1,   IL4↓, 2,   IL4↑, 1,   IL6?, 2,   IL6↓, 35,   IL8↓, 3,   Imm↓, 1,   Imm↑, 8,   Imm↝, 1,   INF-γ↑, 1,   Inflam?, 1,   Inflam↓, 98,   Inflam↑, 2,   IRF3↓, 1,   LPS↓, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 2,   MCP1/CCL2↝, 1,   MyD88↓, 1,   NeuroI↓, 5,   NF-kB↓, 33,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 8,   NLRP3↑, 1,   PGE2↓, 9,   PSA↓, 2,   RAGE↓, 2,   TLR2↓, 2,   TLR4↓, 3,   TLR4↑, 1,   TNF-α?, 1,   TNF-α↓, 44,   TNF-α↑, 1,   VitD↑, 2,   β-HEX↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 2,   pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 3,   Ach↑, 2,   AChE↓, 11,   BChE↓, 3,   BDNF↓, 1,   BDNF↑, 12,   ChAT↑, 1,   GABA↑, 3,   MAOA↓, 3,   MAOB↓, 1,   NGF↑, 1,   PSD95↑, 1,   RELN↑, 1,   SNAP25↑, 1,   TrkB↑, 2,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   APP↓, 3,   Aβ↓, 18,   BACE/β-secretase↓, 9,   PSEN1/PS1↓, 2,   PSEN2/PS-2↓, 1,   tau↓, 8,   p‑tau↓, 9,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

CYP19↓, 1,   DHT↓, 1,   Leptin↓, 1,   PPARγ↓, 3,   PPARγ↑, 3,   p‑PPARγ↓, 1,   testos↓, 1,   testos↑, 1,   TSHR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   BioAv↓, 26,   BioAv↑, 47,   BioAv⇅, 2,   BioAv↝, 18,   BioEnh↑, 3,   ChemoSen↑, 2,   CompStab↑, 2,   CompStab↝, 2,   CYP3A2↓, 1,   Dose?, 1,   Dose↑, 4,   Dose↝, 31,   eff?, 1,   eff↓, 1,   eff↑, 19,   GSTA1↑, 1,   Half-Life↓, 2,   Half-Life↑, 1,   Half-Life↝, 11,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 1,   P450↓, 2,   selectivity↑, 2,   Synergy↑, 87,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 10,   ALP↓, 2,   AST↓, 14,   BloodF↑, 3,   BMD↑, 3,   BP↓, 9,   BP↝, 2,   Calcium↑, 1,   CK/CK-MB↓, 1,   creat↓, 3,   CRP↓, 8,   EGFR↓, 1,   Hcy/homoC↝, 1,   HOMA↓, 1,   hs-CRP↓, 3,   IL6?, 2,   IL6↓, 35,   LDH↓, 3,   Mag↑, 1,   NOS2↓, 1,   PSA↓, 2,   RAGE↓, 2,   TC↓, 3,   TG/TAG↓, 2,   TMAO↓, 1,   UFR↑, 1,   UR↓, 1,   Urea↓, 2,   VitD↑, 2,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 5,   antiAll↑, 9,   AntiArt↑, 5,   AntiCan↑, 17,   AntiDiabetic↑, 15,   AntiMyl↑, 1,   antiPs↑, 2,   AntiTum↓, 1,   AntiTum↑, 3,   cardioP↓, 1,   cardioP↑, 35,   CardioT↓, 1,   chemoP↑, 11,   chemoPv↑, 5,   ChemoSideEff↓, 1,   cognitive↑, 31,   cognitive↝, 1,   diuretic↑, 2,   hepatoP↑, 29,   Learn↑, 3,   memory↑, 25,   Mood↑, 2,   motorD↑, 3,   neuroP↓, 1,   neuroP↑, 64,   Obesity↓, 12,   Pain↓, 5,   QoL↑, 2,   radioP↑, 8,   RenoP↑, 11,   Risk↓, 5,   Sleep↑, 6,   Strength↑, 1,   Stress↓, 2,   Stroke↓, 6,   toxicity↓, 38,   toxicity↑, 2,   toxicity⇅, 1,   toxicity↝, 11,   toxicity∅, 6,   Weight↓, 1,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 6,   AntiFungal↓, 1,   AntiFungal↑, 4,   AntiP↑, 1,   AntiViral↑, 7,   Bacteria↓, 18,   Diar↓, 3,   GutMicro↑, 21,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↑, 3,   Ingr↝, 9,  
Total Targets: 444

Scientific Paper Hit Count for: Synergy, Synergy
23 Curcumin
16 Vitamin C (Ascorbic Acid)
15 Sulforaphane (mainly Broccoli)
15 Melatonin
14 Quercetin
13 Metformin
13 Chrysin
12 Dichloroacetate
11 Lycopene
10 Silver-NanoParticles
10 Chemotherapy
10 EGCG (Epigallocatechin Gallate)
9 Resveratrol
9 immunotherapy
9 mebendazole
8 Artemisinin
8 Ashwagandha(Withaferin A)
8 Fisetin
7 Atorvastatin
7 Berberine
7 Phenethyl isothiocyanate
6 Radiotherapy/Radiation
6 Hyperthermia
6 Magnetic Fields
6 Apigenin (mainly Parsley)
6 Vitamin K2
6 Silymarin (Milk Thistle) silibinin
6 phytic acid, Inositol hexakisphosphate
6 Inositol
6 Bicarbonate(Sodium)
6 Thymoquinone
5 3-bromopyruvate
5 Photodynamic Therapy
5 Dipyridamole
5 Carvacrol
5 diet FMD Fasting Mimicking Diet
5 Fenbendazole
5 Formononetin
5 Flaxseed/Linseed
5 Gambogic Acid
5 Matrine
5 Phycocyanin
5 Rosmarinic acid
5 VitK3,menadione
4 Auranofin
4 Alpha-Lipoic-Acid
4 Gemcitabine (Gemzar)
4 Isothiocyanates
4 Propolis -bee glue
4 Capsaicin
4 salinomycin
4 diet Methionine-Restricted Diet
4 Dandelion Root
4 Disulfiram
4 doxorubicin
4 Hydrogen Gas
4 MCT, metronomic chemo
4 Piperlongumine
4 Urolithin
3 1,8-Cineole
3 Astaxanthin
3 beta-carotene(VitA)
3 Benzyl isothiocyanate
3 borneol
3 Caffeic acid
3 Carnosic acid
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 chaetocin
3 chitosan
3 5-fluorouracil
3 Copper and Cu NanoParticles
3 Piperine
3 Chlorella (Chlorella vulgaris)
3 Spirulina(Arthrospira/Limnospira)
3 Diindolylmethane
3 Mistletoe/Viscum album Extracts
3 Emodin
3 Eugenol
3 Genistein (soy isoflavone)
3 Honokiol
3 Ivermectin
3 Juglone
3 Kaempferol
3 Luteolin
3 methylseleninic acid
3 Terpinen-4-ol / Tea Tree Oil
3 Selenium NanoParticles
3 Zyflamend
2 2-DeoxyGlucose
2 cetuximab
2 Vitamin B12
2 Folic Acid, Vit B9
2 chemodynamic therapy
2 SonoDynamic Therapy UltraSound
2 Trichostatin A
2 Allicin (mainly Garlic)
2 Andrographis
2 isoquercitrin
2 Aspirin
2 Baicalein
2 Biochanin A
2 Betulinic acid
2 Lutein
2 Zeaxanthin
2 Allyl isothiocyanate
2 hydroxychloroquine
2 Thymol-Thymus vulgaris
2 Sorafenib (brand name Nexavar)
2 Camu camu
2 Chlorogenic acid
2 Trastuzumab
2 Citric Acid
2 Coenzyme Q10
2 Ellagic acid
2 Bortezomib
2 Docosahexaenoic Acid
2 Oxygen, Hyperbaric
2 Indole-3-carbinol
2 Vitamin A, Retinoic Acid
2 erastin
2 Exercise
2 Ferulic acid
2 ferumoxytol
2 Fucoidan
2 Gallic acid
2 Cisplatin
2 Gamma-aminobutyric acid
2 Ginkgetin
2 Gossypol/AT-101
2 HydroxyCitric Acid
2 Spermidine
2 L-Theanine
2 Lecithin
2 Mung Bean Sprouts
2 Methyl Jasmonate
2 Magnetic Field Rotating
2 magnetic nanoparticles
2 Lemon Balm/Melissa officinalis
2 Morin
2 Methylsulfonylmethane
2 Niclosamide (Niclocide)
2 Phenylbutyrate
2 Shikonin
2 Selenite (Sodium)
2 Vitamin D3
1 Serotonin, 5-hydroxytryptamine
1 dietMediterranean
1 EMF
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Anti-oxidants
1 Acer okamotoanum
1 5-Aminolevulinic acid
1 almonertinib
1 D-limonene
1 Huperzine A/Huperzia serrata
1 Bufalin/Huachansu
1 Bifidobacterium
1 Boron
1 Boswellia (frankincense)
1 Butyrate
1 Cannabidiol
1 Centella asiatica / Gotu kola → asiaticoside
1 Beta‐Lapachone
1 Chlorophyllin
1 Rutin
1 Cinnamon
1 Hydroxycinnamic-acid
1 Selenium
1 Cucurbitacin
1 Vitamin B1/Thiamine
1 Dasatinib/Phyrago
1 Diclofenac
1 diet Ketogenic
1 Ormeloxifene (Centchroman)
1 Docetaxel
1 Ascorbyl Palmitate
1 Echinacea
1 Electrical Pulses
1 Beta-Caryophyllene
1 temozolomide
1 Geldanamycin
1 Radicicol/monorden
1 carboplatin
1 Flaxseed Oil
1 Arsenic trioxide
1 olaparib/LYNPARZA
1 Galloflavin
1 verapamil
1 Garcinol
1 Ginkgo biloba
1 Germanium Organic/Ge-132 / propagermanium (organogermanium)
1 Ginkgolide B
1 Gold NanoParticles
1 Calorie Restriction Mimetics
1 iodine
1 Inulin Prebiotic
1 Isorhamnetin
1 capecitabine
1 isoorientin
1 itraconazole
1 Recombinant Methioninase
1 tumor necrosis factor-related apoptosis-inducing ligand
1 lambertianic acid
1 Lapatinib
1 low dose naltrexone
1 Licorice
1 Linalool
1 Vitamin E
1 Methylene blue
1 Magnolol
1 Bevacizumab (brand Avastin)
1 gefitinib, erlotinib
1 Dordaviprone; Modeyso
1 Sulindac
1 Modified Citrus Pectin
1 irinotecan
1 MCT oil
1 methotrexate
1 Magnesium
1 Moringa oleifera
1 Zeolite
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Bacopa monnieri
1 Naringin
1 Marjoram (Origanum majorana)
1 Paclitaxel/Taxol
1 topotecan
1 Propranolol
1 Phosphatidylserine
1 Psoralidin
1 Parthenolide
1 Pterostilbene
1 Sulfasalazine
1 Sesamin
1 acetaminophen
1 acetazolamide
1 statins
1 triptolide
1 Turmerones
1 Vitexin
1 Walnut
1 Zinc
1 Bicalutamide
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1849  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page